These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 30086259)
1. Parallel study on protein O-GlcNAcylation in prostate cancer cell with a sensitive microarray biochip. Lei L; Xie J; Yu J; Li Y; Liu Y Anal Biochem; 2018 Oct; 558():53-59. PubMed ID: 30086259 [TBL] [Abstract][Full Text] [Related]
2. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer. Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967 [TBL] [Abstract][Full Text] [Related]
3. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis. Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569 [TBL] [Abstract][Full Text] [Related]
4. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells. Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB. Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989 [TBL] [Abstract][Full Text] [Related]
6. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro. Zhang N; Chen X Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304 [TBL] [Abstract][Full Text] [Related]
7. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice. Nakagawa T; Furukawa Y; Hayashi T; Nomura A; Yokoe S; Moriwaki K; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M Hypertens Res; 2019 Dec; 42(12):1858-1871. PubMed ID: 31409917 [TBL] [Abstract][Full Text] [Related]
11. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054 [TBL] [Abstract][Full Text] [Related]
12. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription. Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide repression of NF-κB target genes by transcription factor MIBP1 and its modulation by O-linked β-N-acetylglucosamine (O-GlcNAc) transferase. Iwashita Y; Fukuchi N; Waki M; Hayashi K; Tahira T J Biol Chem; 2012 Mar; 287(13):9887-9900. PubMed ID: 22294689 [TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer. Li Y; Wang L; Liu J; Zhang P; An M; Han C; Li Y; Guan X; Zhang K Oncogene; 2017 Nov; 36(45):6293-6305. PubMed ID: 28714959 [TBL] [Abstract][Full Text] [Related]
15. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling. Yang YR; Kim DH; Seo YK; Park D; Jang HJ; Choi SY; Lee YH; Lee GH; Nakajima K; Taniguchi N; Kim JM; Choi EJ; Moon HY; Kim IS; Choi JH; Lee H; Ryu SH; Cocco L; Suh PG Oncotarget; 2015 May; 6(14):12529-42. PubMed ID: 25915426 [TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression. Ali A; Kim SH; Kim MJ; Choi MY; Kang SS; Cho GJ; Kim YS; Choi JY; Choi WS Mol Cells; 2017 Jul; 40(7):476-484. PubMed ID: 28681591 [TBL] [Abstract][Full Text] [Related]
17. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification. Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436 [TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644 [TBL] [Abstract][Full Text] [Related]
19. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling. Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217 [TBL] [Abstract][Full Text] [Related]
20. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer. Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]